Actinium Pharmaceuticals, Inc. (ATNM)

CIK 1388320 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Actinium Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Oct 16, 2026DEF 14A0001213900-26-110022
Oct 16, 202640001213900-26-110340
Oct 16, 2026ARS0001213900-26-110024
Oct 16, 202630001213900-26-110337
Oct 15, 20268-K0001213900-26-109884
Oct 9, 2026S-80001213900-26-108558
Sep 10, 202630001213900-26-098841
Sep 10, 202630001213900-26-098842
Sep 4, 202640001213900-26-097745
Sep 4, 202640001213900-26-097740
Sep 4, 202640001213900-26-097742
Sep 4, 202640001213900-26-097739
Sep 4, 202640001213900-26-097741
Sep 4, 202640001213900-26-097744
Aug 14, 20268-K0001213900-26-090232
Aug 7, 202610-Q0001213900-26-086769
Jun 18, 20268-K0001213900-26-070193
May 29, 20268-K0001213900-26-062935
May 8, 202610-Q0001213900-26-053980
Mar 30, 202610-K0001213900-26-036504
Mar 26, 20268-K/A0001213900-26-034807
Feb 13, 20268-K0001213900-26-016559
Nov 26, 20258-K0001213900-25-115586
Nov 14, 202510-Q0001213900-25-110979
Nov 5, 2025ARS0001213900-25-106708